Fortesta® was a testosterone gel prescribed to treat hypogonadism, or low testosterone, in adult men. It is no longer available in the United States.
Fortesta
*image for illustrative purpose only
Fortesta
*image for illustrative purpose only
Fortesta® was a prescription testosterone gel medication used to treat men with hypogonadism, or low testosterone. As a topical gel, Fortesta delivered testosterone transdermally (i.e., through the skin) to help restore normal hormone levels.
Fortesta improved symptoms of hypogonadism, such as fatigue, decreased libido, muscle loss, and mood disturbances. Clinical studies have shown that testosterone replacement therapy (TRT) with medications like Fortesta can enhance energy levels, bone density, and overall well-being in men with confirmed testosterone deficiency.
While Fortesta is no longer available in the United States, other testosterone gels can treat hypogonadism as well as other forms of TRT, including testosterone patches, injections, pellets, and oral pills.
Overall, TRT, including in gel form, should only be used as prescribed by a healthcare provider in order to ensure proper dosing and to minimize risks.
Fortesta (testosterone) is indicated for:
Replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone
Primary hypogonadism (congenital or acquired)
Hypogonadotrophic hypogonadism (congenital or acquired)
Androgen
The most common adverse reaction (incidence ≥3%) is:
Skin reactions at the application site (16.1%)
Fortesta has been discontinued in the US and is no longer available to purchase.
Fortesta has been discontinued and is no longer available for sale in the US. If you’re interested in other prescription testosterone replacement therapies, talk to your healthcare provider about your options.
Men with carcinoma of the breast or known or suspected prostate cancer
Pregnant or breastfeeding women. Testosterone may cause fetal harm
Drug interactions: Androgens may decrease blood glucose and therefore may decrease insulin requirements in diabetic patients, changes in anticoagulant activity may be seen with androgens, use of testosterone with adrenocorticotropic hormone (ACTH) or corticosteroids may result in increased fluid retention
Monitor patients with benign prostatic hyperplasia (BPH) for worsening of signs and symptoms of BPH
Avoid unintentional exposure of women or children to Fortesta
Exogenous administration of androgens may lead to azoospermia
Edema with or without congestive heart failure (CHF) may be a complication in patients with pre-existing cardiac, renal, or hepatic disease
Sleep apnea may occur in those with risk factors
Monitor serum testosterone, prostate specific antigen (PSA), hemoglobin, hematocrit, liver function tests and lipid concentrations periodically
Fortesta is flammable until dry
WARNING: SECONDARY EXPOSURE TO TESTOSTERONE
Virilization has been reported in children who were secondarily exposed to testosterone gel.
Children should avoid contact with unwashed or unclothed application sites in men using Fortesta.
Healthcare providers should advise patients to strictly adhere to recommended instructions for use.
There are alternative treatments to Fortesta available for low testosterone or hypogonadism. Some treatments may be better suited to you than others. If you’re interested in an alternative to Fortesta, connect with a healthcare provider who can help you evaluate your options.
Other types of testosterone replacement therapy (sometimes called androgen replacement) include:
Other topical testosterone medications, such as Androderm® (testosterone patch) and Testim® (testosterone gel)
Implantable testosterone pellets, such as Testopel®
Injectable testosterone medications, such as Aveed®, Azmiro®, Depo®-Testosterone, and Xyosted®
Oral testosterone therapy medications, including Jatenzo®, Kyzatrex®, and Tlando®
Alternatives to TRT that may help manage low testosterone in men include the following, which can signal the body to have or make more testosterone:
Aromatase inhibitors like Arimidex® (anastrozole)
Human chorionic gonadotropin (hCG)
Ovidrel®, a lab-made version of hCG
Selective estrogen receptor modulators like Clomid® (clomiphene)
Your healthcare provider may also prescribe non-medication alternatives that can naturally support healthy testosterone levels, including:
Exercise
Stress management
Dietary improvements
Getting enough sleep
Weight loss
In November 2024, the United States Food and Drug Administration (FDA) provided notice via the Federal Register that Fortesta was not withdrawn from sale due to concerns about its safety or effectiveness. Other than that, there’s no information available on why Fortesta was discontinued.
No, there is no generic form of Fortesta currently available. However, there are other types of testosterone replacement therapy available, including other topical testosterone medications. Ask your healthcare provider about your options.
*This information is from the label for brand name Fortesta®. See the Full Prescribing Information for more complete information. Testosterone, the active ingredient in Fortesta, may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient testosterone.
Drugs.com. (2025). Generic Fortesta availability. https://www.drugs.com/availability/generic-fortesta.html
Edwards RZ, et al. (2020). Improving low testosterone naturally. https://www.va.gov/WHOLEHEALTHLIBRARY/docs/Improving-Low-Testosterone-Naturally.pdf
Federal Register. (2024). Determination that Fortesta (testosterone) gel, 10 milligrams/0.5 gram actuation, was not withdrawn from sale for reasons of safety or effectiveness. https://www.federalregister.gov/documents/2024/11/20/2024-27103/determination-that-fortesta-testosterone-gel-10-milligrams05-gram-actuation-was-not-withdrawn-from
Ide V, et al. (2021). Treatment of men with central hypogonadism: alternatives for testosterone replacement therapy. https://www.mdpi.com/1422-0067/22/1/21
Sizar O, et al. (2023). Androgen replacement. https://www.ncbi.nlm.nih.gov/books/NBK534853/